Mesoblast Limited (ASX:MSB) Completes A$260 Million Capital Raise
Mesoblast Limited raises A$260M to fund the launch of Ryoncil and expand clinical development.
The Hub of Australian Finance News
Mesoblast Limited raises A$260M to fund the launch of Ryoncil and expand clinical development.
EQ Resources Ltd announces Kevin MacNeill’s transition to CTO as part of a growth strategy, focusing on operational improvements.
Saturn Metals Limited reports key activities at Apollo Hill, navigating a challenging quarter while planning significant drilling and financial efforts.
OzAurum Resources (ASX: OZM) has commenced drilling at Mulgabbie North, targeting previously unexplored gold potential.
Peninsula Energy (ASX:PEN) updates on the Lance Project, reporting successful uranium capture and a healthy cash balance.
Tivan Limited (ASX: TVN) reveals ultra high-grade fluorite assays from the Sandover Project, indicating promising exploration and development potential.
Minerals 260 Limited (ASX:MI6) announces the acquisition of the Bullabulling Gold Project, enhancing its gold resource portfolio.
Linius Technologies Limited announces the appointment of Ben Taverner as CEO to drive company growth and market share.
Amcor plc files a preliminary joint proxy statement for its merger with Berry Global Group, detailing financial metrics and management estimates.
Atomo Diagnostics Limited (ASX:AT1) enters a five-year supply agreement with Newfoundland Diagnostics for its HIV self-testing products.